Automated determination of brain parenchymal fraction in multiple sclerosis

American Journal of Neuroradiology

Volumn 34, Issue 3, 2013, Pages 498-504

  Vagberg M ^a   Lindqvist, T ^a   Ambarki, K ^a   Warntjes, J B M ^b   Sundstrom P ^a   Birgander, R ^a   Svenningsson, A ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; AGE; ARTICLE; AUTOMATION; BRAIN PARENCHYMAL FRACTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; PARENCHYMA; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ATROPHY; BRAIN; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84876256396     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3262     Document Type: Article

References (30)

1. Grassiot B, Desgranges B, Eustache F, et al. Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review. J Neurol 2009;256:1397-412
2. Rudick RA, Fisher E, Lee JC, et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999;53:1698-704
3. Kassubek J, Tumani H, Ecker D, et al. Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study. Neuroreport 2003;14:427-30
4. Sharma J, Sanfilipo MP, Benedict RH, et al. Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation. AJNR Am J Neuroradiol 2004;25:985-96
5. Bermel RA, Sharma J, Tjoa CW, et al. A semiautomated measure of whole-brain atrophy in multiple sclerosis. J Neurol Sci 2003;208:57-65
6. Chard DT, Griffin CM, Parker GJ, et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:327-37
7. Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006;5:158-70
8. Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676-95
9. Jovicich J, Czanner S, Han X, et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage 2009;46:177-92
10. Riederer SJ, Lee JN, Farzaneh F, et al. Magnetic resonance image synthesis. Clinical implementation. Acta Radiol Suppl 1986;369:466-68
11. Bobman SA, Riederer SJ, Lee JN, et al. Cerebral magnetic resonance image synthesis. AJNR Am J Neuroradiol 1985;6:265-69
12. Redpath TW, Smith FW, Hutchison JM. Magnetic resonance image synthesis from an interleaved saturation recovery/inversion recovery sequence. Br J Radiol 1988;61:619-24
13. West J, Warntjes JB, Lundberg P. Novel whole brain segmentation and volume estimation using quantitative MRI. Eur Radiol 2012;22:998-07
14. Alfano B, Brunetti A, Arpaia M, et al. Multiparametric display of spin-echo data from MR studies of brain. J Magn Reson Imaging 1995;5:217-25
15. Alfano B, Brunetti A, Covelli EM, et al. Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach. Magn Reson Med 1997;37:84-93
16. Alfano B, Brunetti A, Larobina M, et al. Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis. J Magn Reson Imaging 2000;12:799-807
17. Warntjes JB, Leinhard OD, West J, et al. Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 2008;60:320-29
18. Ambarki K, Lindqvist T, Wåhlin A, et al. Evaluation of automatic measurement of the intracranial volume based on quantitative MR imaging. AJNR Am J Neuroradiol 2012;33:1951-56
19. Ambarki K, Israelsson H, Wahlin A, et al. Brain ventricular size in healthy elderly: comparison between Evans index and volume measurement. Neurosurgery 2010;67:94-99
20. Ambarki K, Wahlin A, Birgander R, et al. MR imaging of brain volumes: evaluation of a fully automatic software. AJNR Am J Neuroradiol 2011;32:408-12
21. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302
22. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician 1983;32:307-17
23. Vrenken H, Geurts JJ, Knol DL, et al. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 2006;240:811-20
24. Ge Y, Grossman RI, Udupa JK, et al. Brain atrophy in relapsingremitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 2000;214:665-70
25. Zivadinov R, Grop A, Sharma J, et al. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of wholebrain atrophy measurement in multiple sclerosis. J Neuroimaging 2005;15:27-36
26. Horsfield MA, Rovaris M, Rocca MA, et al. Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. J Neurol Sci 2003;216:169-77
27. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-89
28. Reed GF, Lynn F, Meade BD. Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 2002;9:1235-39
29. Battaglini M, Jenkinson M, De Stefano N. Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 2011;33:2062-71
30. Chard DT, Jackson JS, Miller DH, et al. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 2010;32:223-28